Resource Center

www.lls.org/resourcecenter

More to Explore - Information About Blood Cancers for Patients, Families and Healthcare Professionals

The Word:

donate

October 23, 2013 - Pediatric ALL - Update on Treatment and Follow-Up Care

Your order contains  item(s)  View Order

Note: The free Adobe Acrobat Reader® is required to view and print Adobe PDF files, and the free Windows Media Player or RealPlayer is required to listen to the MP3 audio files.

Date: October 23, 2013
Time: 1:00 p.m. - 2:30 p.m. ET
Location: Telephone/Web
View: Program Slides | Diapositivas (Spanish program slides)
Read: Transcript
Listen: Presentation | Q&A Session | Presentación y sesión de preguntas (Spanish audio)
Access: Virtual Lecture

Topics Covered

  • Current treatment options for pediatric acute lymphoblastic leukemia (ALL)
  • Clinical trials and emerging therapies for pediatric ALL
  • The importance of follow-up care after treatment ends
  • Side effects management and quality of life issues for patients and caregivers

Speakers

Susan R. Rheingold, MD
Medical Director, Oncology Outpatient Clinic
Attending Physician
The Children's Hospital of Philadelphia
Associate Professor of Clinical Pediatrics, Perelman School of Medicine at the University of Pennsylvania
Philadelphia, PA

Cara Simon, PhD, APRN, CPNP
Pediatric Nurse Practitioner
Outpatient Leukemia/Lymphoma Program
The Children's Hospital of Philadelphia
Philadelphia, PA

Questions Asked by the Pediatric ALL Community

  • Is it common for someone to develop skin rashes similar to eczema, some muscle twitches at night and sometimes just drifting off to sleep after acute lymphoblastic leukemia (ALL) treatment?
  • Please define a relapse and what is the chance of a relapse?
  • How does a patient know which type of ALL he or she has?
  • Can you please discuss the sibling risk of a child with ALL?
  • Please explain minimal residual disease.
  • Are there issues and treatments that are different for infants diagnosed with ALL than for children of an older age?
  • Is there a test specific to ALL patients that can identify cognitive concerns after treatments specifically regarding school?
  • What should guide a parent's decision-making to accept standard treatment or to pursue a study treatment?
  • Is there a difference in outcome between children that have bone marrow transplants and children that have radiation or chemotherapy?
  • What are the long-term risks of ALL treatment?
  • I was wondering about the long-term side effects of mercaptopurine, methotrexate and asparaginase.
  • If a patient has had anaphylaxis, is Erwinia a good choice for treatment?
  • Have you seen small children lose bladder control or don't recognize when they need to go potty? Every bathroom trip for my child with ALL seems to be an emergency.
  • Are cognitive problems a result of chemotherapy or radiation?
  • Do you have any information on urinary retention following vincristine and the prognosis?
  • Can you speak about potential fertility complications after chemotherapy for pediatric leukemia?
  • What are your recommendations for children who were treated at a hospital that does not have a survivorship program?

Sponsors and Supporters

This program is sponsored by The Leukemia & Lymphoma Society and supported by a grant from Jazz Pharmaceuticals.

last updated on Thursday, September 11, 2014
btn_sharethis